anmelden
OMX Copenhagen 20
1.544,40
PKT
+5,93
PKT
+0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen 20-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.01.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 26.01.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 22.01.18 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.01.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 19.01.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.01.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 16.01.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 16.01.18 | Novo Nordisk market-perform | Bernstein Research | |
| 15.01.18 | Novo Nordisk buy | UBS AG | |
| 12.01.18 | Novo Nordisk buy | UBS AG | |
| 09.01.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 09.01.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 08.01.18 | Novo Nordisk buy | UBS AG | |
| 29.12.17 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 15.12.17 | Novo Nordisk Verkaufen | DZ BANK | |
| 12.12.17 | Novo Nordisk buy | UBS AG | |
| 07.12.17 | Novo Nordisk Reduce | HSBC | |
| 06.12.17 | Novo Nordisk overweight | Morgan Stanley | |
| 06.12.17 | Novo Nordisk buy | UBS AG | |
| 06.12.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 06.12.17 | Novo Nordisk buy | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 06.12.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.12.17 | Novo Nordisk overweight | Morgan Stanley | |
| 28.11.17 | Novo Nordisk buy | UBS AG | |
| 22.11.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 22.11.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 22.11.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 16.11.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 15.11.17 | Novo Nordisk Underweight | Barclays Capital | |
| 03.11.17 | Novo Nordisk Hold | S&P Capital IQ | |
| 02.11.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 02.11.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 02.11.17 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
| 02.11.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 02.11.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.11.17 | Novo Nordisk buy | UBS AG | |
| 27.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 26.10.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 23.10.17 | Novo Nordisk buy | UBS AG |